Braun Stacey Associates Boosts Stake in Merck & Co.
Braun Stacey Associates Inc., a financial services company, has increased its stake in Merck & Co. Inc. (NYSE:MRK) by 10.9% during the second quarter, according to the company's latest 13F filing with the Securities and Exchange Commission.
The firm now owns 272,942 shares of Merck & Co.'s stock, valued at $35,073,000 as of its most recent filing.
Merck & Co. has a market capitalization of $365.88 billion and a price-to-earnings ratio of 118.64. The company's dividend payout ratio is 272.00%.